Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223

Radium-223 dichloride (Ra223) represents the unique bone-directed treatment option that shows an improvement in overall survival (OS) in metastatic castrate resistant prostate cancer (mCRPC). However, there is an urgent need for the identification of reliable biomarkers to non-invasively determine i...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancers (Basel)
Auteurs principaux: Bauckneht, Matteo, Capitanio, Selene, Donegani, Maria Isabella, Zanardi, Elisa, Miceli, Alberto, Murialdo, Roberto, Raffa, Stefano, Tomasello, Laura, Vitti, Martina, Cavo, Alessia, Catalano, Fabio, Mencoboni, Manlio, Ceppi, Marcello, Marini, Cecilia, Fornarini, Giuseppe, Boccardo, Francesco, Sambuceti, Gianmario, Morbelli, Silvia
Format: Artigo
Langue:Inglês
Publié: MDPI 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7016706/
https://ncbi.nlm.nih.gov/pubmed/31861942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010031
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires